| Date Filed | Type | Description |
| 06/12/2023 |
4
| ROPER JESS (Director) has filed a Form 4 on BIOLASE, INC|
Txns:
| Granted 512,821 restricted stock units
@ $0 |
|
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2022 |
3
| ROPER JESS (Director) has filed a Form 3 on REVELATION BIOSCIENCES, INC. |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2020 |
4
| ROPER JESS (Director) has filed a Form 4 on BIOLASE, INC|
Txns:
| Granted 165,245 restricted stock units
@ $0
Granted 187,378 options to buy
@ $0.3752, valued at
$70.3k
|
|
| 08/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2018 |
4
| ROPER JESS (Director) has filed a Form 4 on BIOLASE, INC|
Txns:
| Granted 83,333 restricted stock units
@ $0 |
|
| 06/19/2018 |
3
| ROPER JESS (Director) has filed a Form 3 on BIOLASE, INC |
| 04/20/2017 |
4
| ROPER JESS (Former SVP, CFO) has filed a Form 4 on DEXCOM INC |
| 03/24/2017 |
4
| ROPER JESS (SVP, CFO) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 2,000 shares
@ $75.9683, valued at
$151.9k
|
|
| 03/14/2017 |
4
| ROPER JESS (SVP, CFO) has filed a Form 4 on DEXCOM INC|
Txns:
| Disposed/sold 2,538 shares
@ $77.5506, valued at
$196.8k
Disposed/sold 1,948 shares
@ $77.5506, valued at
$151.1k
Disposed/sold 5,120 shares
@ $77.5506, valued at
$397.1k
|
|
| 02/24/2017 |
4
| ROPER JESS (SVP, CFO) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 2,333 shares
@ $78.7649, valued at
$183.8k
|
|
| 01/20/2017 |
4
| ROPER JESS (SVP, CFO) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 3,012 shares
@ $85.0102, valued at
$256.1k
|
|
| 12/16/2016 |
4
| ROPER JESS (SVP, CFO) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 2,442 shares
@ $64.1357, valued at
$156.6k
|
|
| 10/26/2016 |
4
| ROPER JESS (SVP, CFO) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 2,471 shares
@ $80.7545, valued at
$199.5k
|
|
| 09/23/2016 |
4
| ROPER JESS (SVP, CFO) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 2,470 shares
@ $93.99, valued at
$232.2k
|
|
| 09/13/2016 |
4
| ROPER JESS (SVP, CFO) has filed a Form 4 on DEXCOM INC|
Txns:
| Disposed/sold 2,667 shares
@ $93.7226, valued at
$250k
Disposed/sold 3,556 shares
@ $93.7226, valued at
$333.3k
|
|
| 06/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/26/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/15/2016 |
4
| ROPER JESS (SVP, CFO) has filed a Form 4 on DEXCOM INC|
Txns:
| Disposed/sold 2,658 shares
@ $63.9614, valued at
$170k
|
|
| 03/14/2016 |
4
| ROPER JESS (SVP, CFO) has filed a Form 4 on DEXCOM INC|
Txns:
| Disposed/sold 1,988 shares
@ $63.18, valued at
$125.6k
Disposed/sold 5,992 shares
@ $63.18, valued at
$378.6k
|
|
| 03/10/2016 |
4
| ROPER JESS (SVP, CFO) has filed a Form 4 on DEXCOM INC|
Txns:
| Granted 30,000 shares
@ $0.001, valued at
$30 |
|
| 09/10/2013 |
4
| ROPER JESS (VP, CFO) has filed a Form 4 on DEXCOM INC|
Txns:
| Disposed/sold 3,261 shares
@ $26.8894, valued at
$87.7k
|
|
| 06/12/2013 |
4
| ROPER JESS (VP, CFO) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 10,361 shares
@ $22.33, valued at
$231.4k
|
|
| 03/13/2013 |
4
| ROPER JESS (VP, CFO) has filed a Form 4 on DEXCOM INC|
Txns:
| Granted 30,000 shares
@ $0.001, valued at
$30
Disposed/sold 5,001 shares
@ $15.69, valued at
$78.5k
|
|
| 03/13/2012 |
4
| ROPER JESS (VP, CFO) has filed a Form 4 on DEXCOM INC|
Txns:
| Granted 25,625 shares
@ $0.001, valued at
$25.6
Disposed/sold 3,434 shares
@ $10.2583, valued at
$35.2k
|
|
| 03/10/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/16/2010 |
4
| ROPER JESS (VP, CFO) has filed a Form 4 on DEXCOM INC|
Txns:
| Granted 5,510 options to buy
@ $9.8, valued at
$54k
Granted 35,490 options to buy
@ $9.8, valued at
$347.8k
|
|
| 12/15/2008 |
4
| ROPER JESS (VP, CFO) has filed a Form 4 on DEXCOM INC |
| 11/24/2008 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |